A Phase 1b Study to Assess the Safety and Anti-inflammatory Effects of Two Different Doses of SRT2104 in Patients With Ulcerative Colitis
Clinical trial NCT01453491 · COMPLETED
Trial details
- NCT number
- NCT01453491
- Sponsor
- Sirtris, a GSK Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-02-13
- Primary completion
- 2013-03-18
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.